Maisel Urges Caution In Adoption Of Atritech’s Watchman Anti-Stroke Device

If approved by FDA, Atritech's Watchman left-atrial appendage occluder should not be routinely implanted in atrial fibrillation patients to prevent strokes until more is known about the long-term safety and efficacy of the device, according to cardiologist and device safety expert William Maisel